F830-0973 Screening compound: 3-[(3,5-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one

F830-0973 Screening compound: 3-[(3,5-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
F830-0973 Screening compound: 3-[(3,5-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F830-0973
3-[(3,5-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F830-0973

Molecular Formula

C23H19F2N7O4 (C23 H19 F2 N7 O4)

Compound Name

3-[(3,5-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one

IUPAC name

3-[(35-difluorophenyl)methyl]-6-{[3-(4-ethoxy-3-methoxyphenyl)-124-oxadiazol-5-yl]methyl}-3H6H7H-[123]triazolo[45-d]pyrimidin-7-one

SMILES

CCOc(ccc(-c1noc(CN(C=Nc2c3nnn2Cc2cc(F)cc(F)c2)C3=O)n1)c1)c1OC

InChI

InChI=1S/C23H19F2N7O4/c1-3-35-17-5-4-14(8-18(17)34-2)21-27-19(36-29-21)11-31-12-26-22-20(23(31)33)28-30-32(22)10-13-6-15(24)9-16(25)7-13/h4-9,12H,3,10-11H2,1-2H3

InChI Key

RDCWMHLFWVCBQH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD16640411

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.45

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

3.038

Distribution Coefficient, logD

3.038

Water Solubility, LogSw

-3.17

Polar Surface Area

99.206

Acid Dissociation Constant (pKa)

24.68

Base Dissociation Constant (pKb)

2.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

F830-0973 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F830-0973 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F830-0973?
Check Price and Availability of F830-0973, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F830-0973 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F830-0973
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F830-0973
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F830-0973 available by request